共 50 条
- [2] Analysis on heterogeneity of hepatocellular carcinoma immune cells and a molecular risk model by integration of scRNA-seq and bulk RNA-seq [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
- [3] ScRNA-seq and bulk RNA-seq reveal the characteristics of ferroptosis and establish a risk signature in cholangiocarcinoma [J]. MOLECULAR THERAPY-ONCOLYTICS, 2022, 27 : 48 - 60
- [4] Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
- [5] Comprehensive analysis of scRNA-seq and bulk RNA-seq reveal the characteristics of disulfidptosis and a prognostic signature in BLCA [J]. AGING-US, 2024, 16 (06): : 5751 - 5771
- [7] Integration of scRNA-Seq and bulk RNA-Seq uncover perturbed immune cell types and pathways of Kawasaki disease [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
- [9] Coupled scRNA-seq and Bulk-seq reveal the role of HMMR in hepatocellular carcinoma [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15